NCT05451303Recruiting
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Detection of Oral and Throat Cancers Using Saliva Metatranscriptomic Analysis
Source: ClinicalTrials.gov · Last updated 29 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To evaluate the design, safety and efficacy of OralViome Cancer Testing system in the early detection of Oral and Throat Cancers using saliva metatranscriptomic analysis. This study will recruit only at existing clinical sites and will NOT use any additional clinical sites.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 475 (estimated)
- First submitted
- 5 Jul 2022
- Start date
- 27 May 2022
- Primary completion date
- Dec 2026
- Lead sponsor
- Viome
- Diseases
- Head and neck cancer
- NCT number
- NCT05451303
What you commit to
- Study type: Observational
- Planned participants: 475
- From 27 May 2022 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of fertility enhancing medications
Other
- Pregnancy
Who the study is looking for
- Signed Informed Consent obtained
- 18 years and older
- At a high risk of developing oral or throat cancer based on clinician's discretion
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NYMC Coordinator of this site? Confirm its status | New York | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.